A covalent antagonist for the human adenosine A2A receptor
Open Access
- 3 December 2016
- journal article
- research article
- Published by Springer Nature in Purinergic Signalling
- Vol. 13 (2) , 191-201
Abstract
The structure of the human A2A adenosine receptor has been elucidated by X-ray crystallography with a high affinity non-xanthine antagonist, ZM241385, bound to it. This template molecule served as a starting point for the incorporation of reactive moieties that cause the ligand to covalently bind to the receptor. In particular, we incorporated a fluorosulfonyl moiety onto ZM241385, which yielded LUF7445 (4-((3-((7-amino-2-(furan-2-yl)-[1, 2, 4]triazolo[1,5-a][1, 3, 5]triazin-5-yl)amino)propyl)carbamoyl)benzene sulfonyl fluoride). In a radioligand binding assay, LUF7445 acted as a potent antagonist, with an apparent affinity for the hA2A receptor in the nanomolar range. Its apparent affinity increased with longer incubation time, suggesting an increasing level of covalent binding over time. An in silico A2A-structure-based docking model was used to study the binding mode of LUF7445. This led us to perform site-directed mutagenesis of the A2A receptor to probe and validate the target lysine amino acid K153 for covalent binding. Meanwhile, a functional assay combined with wash-out experiments was set up to investigate the efficacy of covalent binding of LUF7445. All these experiments led us to conclude LUF7445 is a valuable molecular tool for further investigating covalent interactions at this receptor. It may also serve as a prototype for a therapeutic approach in which a covalent antagonist may be needed to counteract prolonged and persistent presence of the endogenous ligand adenosine.Keywords
Funding Information
- China Scholarship Council
This publication has 42 references indexed in Scilit:
- Structure of an Agonist-Bound Human A2AAdenosine ReceptorScience, 2011
- The structure and function of G-protein-coupled receptorsNature, 2009
- The 2.6 Angstrom Crystal Structure of a Human A2AAdenosine Receptor Bound to an AntagonistScience, 2008
- Very fast prediction and rationalization of pKa values for protein–ligand complexesProteins: Structure, Function, and Bioinformatics, 2008
- Structural diversity of G protein-coupled receptors and significance for drug discoveryNature Reviews Drug Discovery, 2008
- A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cellsBlood, 2008
- How many drug targets are there?Nature Reviews Drug Discovery, 2006
- A2A adenosine receptor protects tumors from antitumor T cellsProceedings of the National Academy of Sciences of the United States of America, 2006
- High Affinity Electrophilic and Photoactivatable Covalent Endocannabinoid Probes for the CB1 ReceptorJournal of Medicinal Chemistry, 2005
- 8‐(3‐Isothiocyanatostyryl)caffeine is a selective, irreversible inhibitor of striatal A2‐Adenosine receptorsDrug Development Research, 1993